Brittany D. Spitznagel

Brittany D. Spitznagel

Auto-generated profile, based on publicly available information

Brittany D. Spitznagel

Department of Pharmacology, Vanderbilt University, Nashville, TN 37232, USA

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 January 2023 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
MLMaximilian Daniel Lyon
Maximilian Daniel Lyon
PLPing Li
Ping Li
JFJuan J. Ferreira
Juan J. Ferreira
RLRoman M. Lazarenko
Roman M. Lazarenko
SKSujay V. Kharade
Sujay V. Kharade
CSCelia M. Santi
Celia M. Santi
To fertilize an oocyte, the membrane potential of both mouse and human sperm must hyperpolarize (become more negative inside). Determining the molecular mechanisms underlying this hyperpolarization is vital for developing new contraceptive methods and detecting causes of idiopathic male infertility. In mouse sperm, hyperpolarization is caused by activation of the sperm-specific potassium (K+) channel SLO3 [C. M. Santi et al., FEBS Lett.584, 1041–1046 (2010)]. In human sperm, it has long been unclear whether hyperpolarization depends on SLO3 or the ubiquitous K+channel SLO1 [N. Mannowetz, N. M. Naidoo, S. A. S. Choo, J. F. Smith, P. V. Lishko,Elife 2, e01009 (2013), C. Brenker et al., Elife3, e01438 (2014), and S. A. Mansell, S. J. Publicover, C. L. R. Barratt, S. M. Wilson, Mol. Hum. Reprod.20, 392–408 (2014)]. In this work, we identified the first selective inhibitor for human SLO3—VU0546110—and showed that it completely blocked heterologous SLO3 currents and endogenous K+currents in human sperm. This compound also prevented sperm from hyperpolarizing and undergoing hyperactivated motility and induced acrosome reaction, which are necessary to fertilize an egg. We conclude that SLO3 is the sole K+channel responsible for hyperpolarization and significantly contributes to the fertilizing ability of human sperm. Moreover, SLO3 is a good candidate for contraceptive development, and mutation of this gene is a possible cause of idiopathic male infertility.

19 January 2022 in Pharmacology Biochemistry and Behavior
Verified
Journal Article
Closed access
JWJordyn M. Wilcox
Jordyn M. Wilcox
DCDavid Consoli
David Consoli
KPKrista C. Paffenroth
Krista C. Paffenroth
BSBrittany D. Spitznagel
Brittany D. Spitznagel
ECErin S. Calipari
Erin S. Calipari
FHFiona Harrison
Fiona Harrison

29 September 2022 in Bioorganic & Medicinal Chemistry Letters
Verified
Journal Article
Closed access
AQAlshaima'A M. Qunies
Alshaima'A M. Qunies
NMNigam Mishra
Nigam Mishra
BSBrittany D. Spitznagel
Brittany D. Spitznagel
YDYu Du
Yu Du
VAValerie S. Acuña
Valerie S. Acuña
Kyle A. EmmitteKyle A. Emmitte
Kyle A. Emmitte

22 May 2024 in Molecules
Verified
Journal Article
Open access
PDF file
AQAlshaima’a M. Qunies
Alshaima’a M. Qunies
BSBrittany D. Spitznagel
Brittany D. Spitznagel
YDYu Du
Yu Du
PPPaul Peprah
Paul Peprah
Yasmeen MohamedYasmeen Mohamed
Yasmeen Mohamed
Kyle A. EmmitteKyle A. Emmitte
Kyle A. Emmitte
Gain-of-function mutations in the KCNT1 gene, which encodes the sodium-activated potassium channel known as SLACK, are associated with the rare but devastating developmental and epileptic encephalopathy known as epilepsy of infancy with migrating focal seizures (EIMFS). The design of small molecule inhibitors of SLACK channels represents a potential therapeutic approach to the treatment of EIMFS, other childhood epilepsies, and developmental disorders. Herein, we describe a hit optimization effort centered on a xanthine SLACK inhibitor (8) discovered via a high-throughput screen. Across three distinct regions of the chemotype, we synthesized 58 new analogs and tested each one in a whole-cell automated patch-clamp assay to develop structure–activity relationships for inhibition of SLACK channels. We further evaluated selected analogs for their selectivity versus a variety of other ion channels and for their activity versus clinically relevant SLACK mutants. Selectivity within the series was quite good, including versus hERG. Analog 80 (VU0948578) was a potent inhibitor of WT, A934T, and G288S SLACK, with IC50 values between 0.59 and 0.71 µM across these variants. VU0948578 represents a useful in vitro tool compound from a chemotype that is distinct from previously reported small molecule inhibitors of SLACK channels.

21 November 2024 in Molecules
Verified
Journal Article
Open access
PDF file
NMNigam Mishra
Nigam Mishra
BSBrittany D. Spitznagel
Brittany D. Spitznagel
YDYu Du
Yu Du
Yasmeen MohamedYasmeen Mohamed
Yasmeen Mohamed
YQYing Qin
Ying Qin
Kyle A. EmmitteKyle A. Emmitte
Kyle A. Emmitte
Epilepsy of infancy with migrating focal seizures (EIMFS) is a rare, serious, and pharmacoresistant epileptic disorder often linked to gain-of-function mutations in the KCNT1 gene. KCNT1 encodes the sodium-activated potassium channel known as SLACK, making small molecule inhibitors of SLACK channels a compelling approach to the treatment of EIMFS and other epilepsies associated with KCNT1 mutations. In this manuscript, we describe a hit optimization effort executed within a series of 2-aryloxy-N-(pyrimidin-5-yl)acetamides that were identified via a high-throughput screen. We systematically prepared analogs in four distinct regions of the scaffold and evaluated their functional activity in a whole-cell, automated patch clamp (APC) assay to establish structure-activity relationships for wild-type (WT) SLACK inhibition. Two selected analogs were also profiled for selectivity versus other members of the Slo family of potassium channels, of which SLACK is a member, and versus a panel of structurally diverse ion channels. The same two analogs were evaluated for activity versus the WT mouse channel as well as two clinically relevant mutant human channels.